Knowledge graph · Cancer
Benign Prostatic Hyperplasia
subtype
- Identifier
- CI-CAN-00007306
- Entity page
- /cancer/benign-prostatic-hyperplasia ↗
- Edges
- 65
- Neighbours
- 10 trials
- Drawn
- 10 of 10 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Benign Prostatic Hyperplasia studied in …STUDIED_INderived10 of 65show all (up to 200) | ||||||||
| → studied in | NCT05148156NA · recruiting Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 65 trials mapped (19 active) | — | — | Benign Prostatic Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06511141NA · recruiting | |||||||